Market Herald logo

Find out more about this capital raise

Be the first with the news that moves the market
  • BlackEarth Minerals (BEM) has entered into a trading halt to plan an upcoming capital raise
  • So far, it is unknown how much the company is aiming to raise or where the funds will be spent
  • BlackEarth shares will be paused until Monday, April 12, or when more information about the raise has been released to the market
  • On the market, BlackEarth last traded for 15.5 cents on April 7

BlackEarth Minerals (BEM) has entered into a trading halt ahead of an upcoming capital raise.

Currently, it is unknown how much the company is aiming to raise or where the funds will be spent.

Under the halt, BlackEarth shares will be paused until Monday, April 12, or when more information about the raise has been released to the market.

BlackEarth is a vertically integrated graphite developer with advanced mining projects in Madagascar and base metal prospects in Western Australia.

Last week, the company saw outstanding results from its stage two large-scale pilot test program.

Initial results have confirmed grades of fixed carbon content of over 95 per cent, reaffirming the high quality of graphite product from the Maniry Project.

According to the company, these initial results have re-confirmed the product from the Maniry is high quality.

On the market, BlackEarth last traded for 15.5 cents on April 7.

BEM by the numbers
More From The Market Herald

" Askari Metals (ASX:AS2) plans to raise capital for lithium purchase

Askari Metals (AS2) has entered a trading halt as it plans an upcoming capital raise.
Telix Pharmaceuticals (ASX:TLX) - CEO, Christian Behrenbruch

" Telix Pharmaceuticals (ASX:TLX) planning capital raise

Telix Pharmaceuticals (ASX:TLX) enters a trading halt while it plans an upcoming capital raise.
Alice Queen (ASX:AQX) - Managing Director, Andrew Buxton

" Alice Queen (ASX:AQX) halts trade ahead of fresh capital

Mineral exploration company Alice Queen (ASX:AQX) has entered a trading halt ahead of a proposed capital…
Arovella Therapeutics (ASX:ALA) - CEO and Managing Director, Dr Michael Baker

" Arovella Therapeutics (ASX:ALA) enters trading halt

Arovella Therapeutics (ASX:ALA) enters a trading halt as it plans for an upcoming capital raise.